Patent intelligence · US
US 11559556
Citrus fruit extract-mediated synthesis of tellurium nanomaterials having biomedical applications
Citrus fruit extract-mediated synthesis of tellurium nanomaterials having biomedical applications
Patent details — US 11559556
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 24, 2023
- Expiration
- Jan 19, 2043
- Applicant
- Northwestern University
- Claims
- 8
- CPC classes
- A61K, A61K33/04, A61K36/752, A61K9/5115
Quick answer
US 11559556 (Citrus fruit extract-mediated synthesis of tellurium nanomaterials having biomedical applications) is held by Northwestern University. Status: granted. Granted Jan 24, 2023. Expires Jan 19, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Northwestern University
- Grant date
- Expiration
- Claims
- 8
- CPC classes
- A61K, A61K33/04, A61K36/752, A61K9/5115, A61K9/5123, A61K9/5161
More from Northwestern University
Related pharmaceutical patents in our USPTO index.
-
US 12421280
Insulin like growth factor binding protein bioactive peptide fragments
granted -
US 12414995
Bifunctional compounds comprising Apcin-A and their use in the treatment of cancer
granted -
US 12414981
JNK inhibitors for use in treating and preventing neurodegenerative disorders
granted -
US 12414963
Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin
granted -
US 12415995
Bacterial toxins and uses thereof as Ras specific proteases for treating cell proliferation diseases and disorders
granted -
US 12409205
Nanomolecules for the treatment of inflammatory bowel diseases
granted -
US 12410474
Methods, kits, and devices for diagnosing, prognosing, and treating psychiatric disorders in a patient
granted -
US 12404533
Bioconjugate vaccines' synthesis in prokaryotic cell lysates
granted
Frequently asked questions
What is US patent 11559556?
US 11559556 (Citrus fruit extract-mediated synthesis of tellurium nanomaterials having biomedical applications) is held by Northwestern University. Status: granted. Granted Jan 24, 2023. Expires Jan 19, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11559556?
Northwestern University is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 595 pharmaceutical patents for this assignee.
When does US 11559556 expire?
Our index shows an expiration date of Jan 19, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.